Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma

scientific article published on 01 May 2000

Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1045094082
P356DOI10.1046/J.1523-1747.2000.00958.X
P698PubMed publication ID10771475

P2093author name stringBröcker EB
Zeuthen J
Becker JC
Straten PT
Terheyden P
Vetter CS
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectmetastatic melanomaQ18975855
P304page(s)941-947
P577publication date2000-05-01
P1433published inJournal of Investigative DermatologyQ3186921
P1476titleExpression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma
P478volume114

Reverse relations

cites work (P2860)
Q44996376Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography
Q52014778CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
Q40709378Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones
Q40059638Expression of ligands to NKp46 in benign and malignant melanocytes.
Q35001616IFN-gamma suspends the killing license of anti-tumor CTLs
Q57732968Immunotherapy of malignant melanoma – Basic principles and novel therapeutic approaches
Q35034899Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages
Q34240921Positive psychosocial factors and NKT cells in ovarian cancer patients
Q77667246Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
Q35671699Tumor vaccines.

Search more.